{"id":"W2947019202","doi":"10.1186/s13023-019-1078-5","title":"Comparing access to orphan medicinal products in Europe","year":2019,"lang":"en","type":"article","venue":"Orphanet Journal of Rare Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":87,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Health Technology Assessment international; Shire","keywords":"Reimbursement; Orphan drug; Authorization; Marketing authorization; European union; Business; Access to medicines; Medicine; Public health; Economic growth; Health care; International trade; Economics","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005177018,0.0002306487,0.0005894942,0.003896366,0.0002045818,0.002592144,0.0003730788,0.0006172194,0.003759839],"category_scores_gemma":[0.01404589,0.0001414589,0.001125525,0.004976635,0.0006188496,0.001509454,0.001579875,0.0005350155,0.0003217229],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009111993,"about_ca_system_score_gemma":0.0008438182,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005332503,"about_ca_topic_score_gemma":0.003081873,"domain_scores_codex":[0.9946069,0.001702451,0.001008658,0.000964698,0.001178492,0.0005387461],"domain_scores_gemma":[0.9823363,0.005990895,0.008518283,0.0005392067,0.001543494,0.001071755],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002215117,0.0001783164,0.9321,0.001119758,0.001979315,0.0004879961,0.001224174,0.001109595,0.00046199,0.003357691,0.002518512,0.05324765],"study_design_scores_gemma":[0.00009103517,0.0004111026,0.9794082,0.0005675468,0.0003749458,0.0009775911,0.001181671,0.000247569,0.0002558139,0.0003500094,0.01610933,0.00002519044],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9628403,0.01767043,0.0007032485,0.0007701049,0.00008083499,0.00004831888,0.005777269,0.00002252886,0.012087],"genre_scores_gemma":[0.9907775,0.003403486,0.0005246706,0.0003440252,0.00007844446,0.00003445496,0.004200131,0.0000158764,0.0006215391],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005332503,"threshold_uncertainty_score":0.02737904,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2640322262541501,"score_gpt":0.4082072618626137,"score_spread":0.1441750356084636,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}